amanitins has been researched along with Carcinoma--Squamous-Cell* in 1 studies
1 other study(ies) available for amanitins and Carcinoma--Squamous-Cell
Article | Year |
---|---|
Inhibition of agonist-induced activation of phospholipase C following poxvirus infection.
Recent studies indicate that viruses may influence polyphosphoinositide levels. This study has examined the effects of vaccinia virus infection on phospholipase C activity. Infection of BS-C-1 cells, an African Green Monkey kidney cell line, or A431 cells, a human carcinoma cell line, with vaccinia virus inhibits receptor-mediated phospholipase C activation. As a consequence, agonist-mediated Ca2+ mobilization in BS-C-1 cells also was inhibited by vaccinia virus infection. Alleviation of the inhibition of phospholipase C activation was observed in vaccinia virus-infected cells treated with cycloheximide without influencing uninfected cells. Treatment of infected cells with alpha-amanitin, an inhibitor of host mRNA synthesis but not virus mRNA synthesis, failed to alleviate the inhibition of phospholipase C activation. Together these results suggest that a virus-encoded gene product mediates the inhibition of phospholipase C activation without the need of a virus-induced host factor. Analysis of the processes involved in the formation of inositol (1,4,5)-trisphosphate and mobilization of intracellular Ca2+ indicate that the vaccinia virus gene product exerts its inhibitory effects at the level of phospholipase C activity. This may occur by either directly reducing the amount of phospholipase C, reducing the specific activity of phospholipase C, or by inhibiting the association of phospholipase C with its substrate, phosphatidylinositol 4,5-bisphosphate. Topics: Adenosine Triphosphate; Amanitins; Animals; Calcium; Carcinoma, Squamous Cell; Cell Line; Cell Transformation, Viral; Chlorocebus aethiops; Cycloheximide; Enzyme Activation; Humans; Inositol; Inositol 1,4,5-Trisphosphate; Inositol Phosphates; Kidney; Kinetics; RNA, Messenger; Tumor Cells, Cultured; Type C Phospholipases; Vaccinia virus | 1992 |